Ali Zeaiter - Clin Dev, PharmaMar | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 50 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Lurbinectedin in Patients with Small Cell Lung Cancer with Chemotherapy-Free Interval ≥30 Days and Without Central Nervous Metastases

Solange Peters,Jose Trigo,Benjamin Besse,Victor Moreno,Alejandro Navarro,Maria Eugenia Olmedo,Luis Paz-Ares,Christian Grohe,Jose Antonio Lopez-Vilarino,Cristian Fernandez,Carmen Kahatt,Vicente Alfaro,Antonio Nieto,Ali Zeaiter,Vivek Subbiah

LUNG CANCER (2024)

引用0浏览0WOS引用

Randomized Controlled, Open-Label, Phase IIb/III Study of Lurbinectedin in Combination with Doxorubicin Versus Doxorubicin Alone As First-Line Treatment in Patients with Metastatic Leiomyosarcoma

Gregory Michael Cote,Sant P. Chawla,George Demetri,Bernd Kasper,Robin Lewis Jones,Javier Martin Broto, Joseph Wooley,Mia C. Weiss,Salvatore Tafuto,Giuseppe Badalamenti,Irene Carrasco-Garcia,Paloma Peinado,Jean-Yves Blay, Gaston Boggio,Cristian Marcelo Fernandez,Antonio Nieto,Carmen Maria Kahatt,Ali Hassan Zeaiter,Axel Le Cesne

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug-Drug Interaction Study

Irene Moreno,Tatiana Hernandez,Emiliano Calvo,Salvador Fudio,Carmen Kahatt,Cristian Fernandez, Jorge Luis Iglesias,Gema Corral,Laura Perez-Ramos, Lola Montilla,Ali Zeaiter,Rubin Lubomirov

Pharmaceuticalsno. 2 (2024): 182-182

引用0浏览0WOS引用

Pharmacokinetics and Safety of Lurbinectedin Administrated with Itraconazole in Cancer Patients: A Drug-Drug Interaction Study

Irene Moreno,Tatiana Hernandez,Emiliano Calvo,Salvador Fudio,Carmen Kahatt,Sara Martinez, Jorge Luis Iglesias, Roman Octavio Calafati,Laura Perez-Ramos, Lola Montilla,Ali Zeaiter,Rubin Lubomirov

MARINE DRUGS（2024）

引用0浏览0WOS引用

A Model-Based Head-to-head Comparison of Single-Agent Lurbinectedin in the Pivotal ATLANTIS Study

Salvador Fudio,Laura Perez-Ramos,Eduardo Asin-Prieto,Ali Zeaiter,Rubin Lubomirov

Frontiers in Oncology（2023）

引用0浏览0WOS引用

Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study

Rebecca Kristeleit,Alexandra Leary,Jean Pierre Delord,Victor Moreno,Ana Oaknin,Daniel Castellano, Geoffrey I. Shappiro,Cristian Fernandez,Carmen Kahatt,Vicente Alfaro,Mariano Siguero,Daniel Rueda,Ali Zeaiter,Ahmad Awada,Ana Santaballa,Khalil Zaman,Jalid Sehouli,Vivek Subbiah

Investigational new drugsno. 5 (2023): 677-687

引用0浏览0WOS引用

Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients with Advanced Solid Tumours

Alexandra Leary,Ana Oaknin,Jose Manuel Trigo, Victor Moreno,Jean-Pierre Delord,Valentina Boni,Irene Brana,Cristian Fernandez,Carmen Kahatt,Antonio Nieto,Martin Cullell-Young,Ali Zeaiter,Vivek Subbiah

European journal of cancer（2023）

引用0浏览0WOS引用

Phase I Study of Plitidepsin in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/refractory Multiple Myeloma

Maria Victoria Mateos,Felipe Prosper,Jesus Martin Sanchez,Enrique M. Ocio,Albert Oriol,Cristina Motllo,Jean-Marie Michot,Isidro Jarque,Rebeca Iglesias, Maria Sole,Sara Martinez,Carmen Kahatt,Salvador Fudio,Gema Corral,Ali Zeaiter, Lola Montilla,Vincent Ribrag

Cancer medicine（2022）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn